Abstract
Impulse control disorders (ICD) can be triggered by dopamine replacement therapies in patients with Parkinson's Disease (PD). Previous studies have identified several risk factors associated with ICD. In this study we investigated the presence of white matter (WM) microstructural changes at baseline in a cohort of drug-naïve PD patients who successively developed ICD over a 36-month follow-up period (ICD+) compared with patients who did not (ICD-).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
